NTLA-2002, the investigational gene-editing therapy from Intellia Therapeutics, reduced the number of monthly swelling attacks by a mean of…
Articles by Andrea Lobo
The risk of venous thromboembolism (VTE), which occurs when a blood clot forms in a vein and obstructs blood flow,…
The case of a man with a rare form of hereditary angioedema (HAE) where the levels of the C1-inhibitor…
Most people with hereditary angioedema (HAE) can usually predict an impending swelling attack based on early, or prodromal, signs…
An 83-year-old woman suddenly developed angioedema of the airway as a result of neck trauma while being treated with…
Mutations in the CPN1 gene leading to a deficiency in the activity of the carboxypeptidase N (CPN) enzyme were found…
A 60-year-old man with hereditary angioedema (HAE) caused by an unknown mutation developed visual loss due to swelling of…
Long-term preventive treatment with Haegarda reduced the number and severity of attacks and the use of rescue medications in…
Long-term prophylaxis, or preventive treatment, with Orladeyo (berotralstat) is well tolerated, and results in sustained reductions in swelling attacks…
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended the approval…